CRA Financial Services’s Matinas BioPharma MTNB Stock Holding History

CRA Financial Services’s Portfolio MTNB Stock Details MTNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-200	Closed	-$1.58K	–	270
2024 Q2	$1.58K	Hold	200	–	–	﹤0.01%	251
2024 Q1	$2.71K	Hold	200	–	–	﹤0.01%	240
2023 Q4	$2.16K	Hold	200	–	–	﹤0.01%	217
2023 Q3	$1.3K	Hold	200	–	–	﹤0.01%	203
2023 Q2	$3.6K	Hold	200	–	–	﹤0.01%	208
2023 Q1	$4.7K	Hold	200	–	–	﹤0.01%	204
2022 Q4	$5K	Hold	200	–	–	﹤0.01%	203
2022 Q3	$6K	Hold	200	–	–	﹤0.01%	189
2022 Q2	$8K	Hold	200	–	–	﹤0.01%	202
2022 Q1	$8K	Hold	200	–	–	﹤0.01%	206
2021 Q4	$10K	Hold	200	–	–	﹤0.01%	206
2021 Q3	$13K	Hold	200	–	–	﹤0.01%	197
2021 Q2	$8K	Hold	200	–	–	﹤0.01%	191
2021 Q1	$11K	Hold	200	–	–	﹤0.01%	179
2020 Q4	$14K	Hold	200	–	–	0.01%	161
2020 Q3	$8K	Hold	200	–	–	﹤0.01%	145
2020 Q2	$8K	Hold	200	–	–	﹤0.01%	140
2020 Q1	$6K	Hold	200	–	–	﹤0.01%	127
2019 Q4	$23K	Hold	200	–	–	0.01%	149
2019 Q3	$6K	Hold	200	–	–	﹤0.01%	139
2019 Q2	$9K	Hold	200	–	–	0.01%	141
2019 Q1	$11K	Hold	200	–	–	0.01%	140
2018 Q4	$6K	Buy	+200	New	+$7.85K	﹤0.01%	132

Other funds holding MTNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

CRA Financial Services's MTNB Position: Q3 2024 in Review

CRA Financial Services sold out of Matinas BioPharma (MTNB) in Q3 2024, closing a stake of 200 shares — an estimated $1.58K sold.

CRA Financial Services first reported a position in MTNB in Q4 2018 and held it in 23 quarters. The position peaked at $23K in Q4 2019. 18 funds tracked by Wall St. Rank hold MTNB as of Q3 2024.

CRA Financial Services reported no remaining Matinas BioPharma position as of Q3 2024 after selling out during the quarter.
CRA Financial Services sold 200 Matinas BioPharma shares in Q3 2024, an estimated $1.58K.
CRA Financial Services first reported a position in Matinas BioPharma in Q4 2018 and held it in 23 quarters.
CRA Financial Services's Matinas BioPharma position peaked at $23K in Q4 2019.
18 funds tracked by Wall St. Rank held Matinas BioPharma as of Q3 2024.

Based on CRA Financial Services's 13F filing for Q3 2024, filed 10 Oct 2024.